Dualitas Therapeutics News and Activities

Acquisition, funding and merger involving Dualitas Therapeutics.

• Dualitas Therapeutics has just announced a $65 Million fundraising (posted on September 19 2025).

View the org chart displaying its 12 main executives

Most searched biographies at Dualitas Therapeutics

• Rich Murray, Interim Chief Executive Officer and Director
• Thomas Hudson, Director
• Nikola Trbovic, Director

Popular executive movements at Dualitas Therapeutics

• Ursula Jeffry has joined the company as Vice President, Nonclinical Development  (posted on March 23 2026).

Create your alert
to follow the executive moves at Dualitas Therapeutics.

Dualitas Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Dualitas Therapeutics

Social media about Dualitas Therapeutics

• Dualitas Therapeutics on Wikipedia, Google News & Yahoo Finance
• Dualitas Therapeutics on LinkedIn, X (Twitter) & YouTube